The Market Checkup: Type 2 Diabetes

In this edition of The Motley Fool's Market Checkup, health-care analysts David Williamson and Max Macaluso discuss the complex nuances of the type 2 diabetes market. From the most successful blockbusters on the market today to revolutionary experimental drugs, this is an increasingly competitive space that investors need to watch closely.

It's no secret that biotech stocks have been soaring recently, but the best investment strategy is to pick great companies and stick with them for the long-term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" shares stocks that could help you build not only long-term wealth, but also winning strategies that every investor should know. Click here to grab your free copy today

The article The Market Checkup: Type 2 Diabetes originally appeared on Fool.com.

David Williamson and Max Macaluso, Ph.D., have no position in any stocks mentioned. The Motley Fool recommends and owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.